Fundraising Fox
/Companies
Sign in

MuReva

Brecksville, US · Founded 2018 · 3 known investors

Find your way into MuReva

Each arrow is one introduction. Sign up to fill in the first one.

293 people can intro you to Sam

Ask Manish Bhandari to introduce you to Sam Shelnutt

You →Manish · together at MuReva →Sam

32 people can intro you to Michael

Ask Jamie Chen to introduce you to Michael Marotta

You →Jamie · together at MuReva →Michael

Sign up to find every way you can get introduced to MuReva

  • Your email: who you already know at MuReva, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the MuReva team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy. Spun off from fiber-optic lighting company Lumitex, its light-transmission technology is being evaluated in a U.S. multicenter clinical trial and is not yet commercially available.

Advanced ManufacturingHardwareHealthtechMedical Devices

Founders & leadership

VKVedang Kothari
Vedang KothariPresident
SSSam Shelnutt
Sam ShelnuttVice-President of EngineeringSam Shelnutt is Vice-President of Engineering at MuReva Phototherapy, an oral phototherapy device company spun from Lumitex. He has extensive experience leading engineering teams in medical device development, with expertise in quality management systems, FDA regulatory compliance (CFR Part 820), and ISO standards (13485, 14971).
MMMichael Marotta
Michael MarottaVice President of Clinical AffairsVice President of Clinical Affairs at MuReva Phototherapy, which develops oral phototherapy devices to reduce side effects in cancer patients undergoing radiation and chemotherapy. His background includes experience in clinical research compliance, working with sponsoring companies, contract research organizations, and investigators across device, biologic, and pharmaceutical research.
PB
Peter BroerNamed on SEC filing
CM
Creighton MurchNamed on SEC filing
ARAustin Ruhle
Austin RuhleChief Financial Officer

Investors · 3

Band of Angelslisted by Band of AngelsSilicon Valley
Jumpstart Ventureslisted by Jumpstart VenturesCleveland · $500K – $2M

How we know: Jumpstart Ventures's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.3M disclosed across 1 round · 2018

▶$1.3MraisedDec 2018 · 18 investors · Manufacturing
Rule 506(b)
Officers, directors & promoters on the filing
  • Peter BroerDirector
  • Vedang Phototherapy KothariExecutive Officer
  • Creighton MurchDirector
  • Austin RuhleExecutive Officer, Director
Offering amount
$1.5M
Amount sold
$1.3M
Minimum investment
$25K
First sale
Dec 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

MuReva Phototherapy Selected as One of Top Emerging Life Sciences Companies in Southern California - MuReva Phototherapymurevapt.com · Apr 2022News - MuReva Phototherapymurevapt.com · Jan 2021

Frequently asked questions

What does MuReva do?
MuReva Phototherapy develops oral phototherapy devices intended to reduce dose-limiting side effects, such as oral mucositis, in cancer patients undergoing radiation and chemotherapy. Spun off from fiber-optic lighting company Lumitex, its light-transmission technology is being evaluated in a U.S. multicenter clinical trial and is not yet commercially available.
Who are MuReva's investors?
MuReva's investors include Angel Physicians Fund, Band of Angels, Jumpstart Ventures.
How much funding has MuReva raised?
MuReva has disclosed $1.3M raised across 1 round.
Where is MuReva headquartered?
MuReva is headquartered in Brecksville, US.